anti EBNA3C car t from Creative Biolabs that has expanded to the entire new drug discovery and development pipeline, including early discovery, preclinical testing, process development, cGMP manufacturing, phase 261-III clinical trials. https://www.creative-biolabs.com/car-t/target-ebna3c-37.htm